An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony histologicznie chłoniak rozlany z dużych komórek B, który nawrócił lub nie zareagował na jedną linię leczenia ogólnego.
- •Pacjent będzie leczony glofitamabem lub rozpoczął takie leczenie nie wcześniej niż 3 miesiące przed rozpoczęciem badania.
✗ Disqualifies
- •Osoby, które obecnie biorą udział lub planują wziąć udział w innym badaniu klinicznym z interwencją.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 2, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (19)
Cancer Hospital Chinese Academy of Medical Sciences.
Langfang, China
Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center
Tianjin, China
Peking University People's Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The First Bethune Hospital of Jilin University
Changchun, China
West China Hospital of Sichuan University
Chengdu, China
Guangdong Provincial People's Hospital
Guangzhou, China
Harbin Medical University Cancer Hospital
Harbin, China
Shandong Cancer Hospital
Jinan, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
Tianjin Cancer Hospital
Tianjin, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology
Wuhan, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, China
The First Affiliated Hospital of Xian Jiao Tong University
Xi'an, China
Yantai Yu Huangding Hospital
Yantai, China
Henan Cancer Hospital
Zhengzhou, China
Queen Mary Hospital
Hong Kong, Hong Kong
Trial contact
Reference Study ID Number: ML45172 https://forpatients.roche.com/ No attachments to email below.
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.